Total medical devices industry M&A deals worth $15.6bn were announced globally in Q3 2022, led by CVS Health’s $8bn acquisition of Signify Health, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 173.7% over the previous quarter of $5.71bn and a drop of 38% when compared with the last four-quarter average, which stood at $25.19bn.

Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $14.53bn. At the country level, the US topped the list in terms of deal value at $14.53bn.

In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in Q3 2022 was the US with 64 deals, followed by the UK with ten and Germany with eight.

In 2022, at the end of , M&A deals worth $28.82bn were announced globally in medical devices industry, marking a decrease of 58.9% year on year.

M&A deals in medical devices industry in Q3 2022: Top deals

The top five M&A deals in medical devices industry accounted for 58.9% of the overall value during Q3 2022.

The combined value of the top deals stood at $13.74bn, against the overall value of $15.6bn recorded for the quarter.

The top five medical devices industry medical devices deals of Q3 2022 tracked by GlobalData were:

1) CVS Health’s $8bn acquisition deal with Signify Health

2) The $3.9bn acquisition of 1Life Healthcare by

3) McKesson’s $875m acquisition deal with Rx Savings Solutions

4) The $500m acquisition of OpenEye Scientific Software by Cadence Design Systems

5) Azenta’s $468.22m acquisition deal with B Medical Systems